Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
SYK inhibitors
print preview
bookmark
share with colleague
General Information
Company
Gilead Sciences Inc.
Description
Spleen tyrosine kinase inhibitors
Molecular Target
Spleen tyrosine kinase (SYK)
Mechanism of Action
Latest Stage of Development
Preclinical
Indication
Rheumatoid arthritis (RA)
Partner
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Archive Items are loading
Set Email Alert
dummy
General Information